MeSH 搜索器

Immunotherapy, Adoptive

Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
推出的年份: 1991
副标题
树号: E02.095.465.425.400.330.050.400, E05.478.550.520.050.400
MeSH 单一 ID: D016219
进入的组:
  • Immunotherapy, Adoptive Cellular
  • Adoptive Immunotherapy
  • Adoptive Immunotherapies
  • Immunotherapies, Adoptive
  • Cellular Immunotherapy, Adoptive
  • Adoptive Cellular Immunotherapies
  • Cellular Immunotherapies, Adoptive
  • Immunotherapies, Adoptive Cellular
  • Adoptive Cellular Immunotherapy
  • Chimeric Antigen Receptor Therapy
  • CAR T-Cell Therapy
  • CAR T Cell Therapy
  • CAR T-Cell Therapies
  • T-Cell Therapies, CAR
  • T-Cell Therapy, CAR
  • Therapies, CAR T-Cell
  • Therapy, CAR T-Cell
早前的内容:
  • Immunization, Passive (1983-1990)

留言 (0)

沒有登入
gif